Approximately 41% (33/81) of ovarian carcinomas exhibited methylation in the CCBE1 promoter as compared with 20% (1/5) NOSE and 0% (0/4) normal ovarian stroma samples (Table 1). Here, CCBE1 is linked to ovarian carcinoma.